Phase II trial using combination of TACE and SBRT for unresectable single large HCC: preliminary report

Michael Buckstein; E. Kim; Alan J. Fischman; M. Facciuto; M. Sung; Bachir Taouli; Josep M. Llovet; M. Schwartz; K. Rosenzweig

doi:10.1016/s0168-8278(18)30638-x

Related publications

Article2016

Concrete Pipe: Electrochemical Cell, Phase II: Final Report

Francisco Presuel-moreno

Article2018

Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Takuji Torimura, Nobukazu Tanabe, Hiroshi Aikata, Namiki Izumi, Takahiro Yamasaki, Shunsuke Nojiri, Keisuke Hino, Hidetaka Tsumura, Teiji Kuzuya, Norio Isoda, Kohichiroh Yasui, Kenichi Yoshimura, Takuji Okusaka, Junji Furuse, Norihiro Kokudo, Kiwamu Okita, Yasuaki Arai

Article1991

MALARIAL RETINOPATHY - A PRELIMINARY-REPORT

W E Schulenburg, Sir Nicholas White, Tatiana Davis, S Boonamiung, Yupin Suputtamongkol, Sara Ford

Investigative Ophthalmology & Visual Science

Article2001

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

Josep M. Llovet, María Isabel Real, R. Vilana, Ramón Planas, S. Coll, John J. Aponte, Carmen Ayuso, María Sala, Jordi Muchart, R. Costa, J Rodés, Jordi Bruix

Journal of Hepatology

Article2002

PRELIMINARY REPORT ON THE ENERGY BALANCE METHOD FOR NONLINEAR OSCILLATORS

Ji-huan He